UNIQUE in the industry Pharmawiser™
is fully compatible with Germany's January 2011 revolutionary reimbursement law
Patient-based and Indication-based Price Design and Access Forecasting
Pharmawiser™, the unparalleled pricing and forecasting simulator uses the same modular approach and
basic parameters as those required for AMNOG* reimbursement filing, guaranteeing aligned and transparent strategy design.
ALLIANCE Concepts is committed to enhance your brand's revenue and earnings based on each country's truths and this worldwide.
*AMNOG = ArzneimittelMarktNeuOrdnungsGesetz
Contact us for details also for info and expert opinion on AMNOG impact and consequences for the industry.
to be scheduled
July 2009 London SMi Pricing Masterclass
'The Winds of Change in Pharma and Biotech Pricing.
Zooming in on Pricing Strategies for Biosimilars.'
Contact SMi for full information
request presentation via User Login
July 2008 London SMi Pricing Masterclass
At the SMi-organized masterclass on Developing and Implementing
Pricing and Reimbursement Strategies, Chris Van Mol was invited as a workshop leader.
She focused on case studies demonstrating the importance of
well-planned launch sequencing.
request free presentation via User Login
July 2007 Copenhagen iHEA 6th World Congress ~Explorations in
Chris Van Mol presented a paper on Realizing global pharma price
optimization in a cost-contained environment.
download full paper presentation ref.# 9845 via User Login
January 2007 Rome Jacob Fleming Conference on Pharma Pricing
Chris Van Mol participated as an expert speaker and co-sponsor
of this event.
The presentation topic was “Protect and sustain profits by using
an inter-country pricing simulator.”
see conference program ref.# 9846 via User Login
get free conference presentation via User Login.